OA12.06 Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable EGFR-mutated NSCLC (AEGEAN)
Jianxing He, Shugeng Gao, Martin Reck, David Harpole, Tetsuya Mitsudomi, Janis M. Taube, Kyung‐Yil Lee, Yoshitsugu Horio, Y. Runglodvatana, Mike Aperghis, Gary J. Doherty, Peter J. Laud, Tamer M. Fouad, John V. Heymach
Topics & Concepts
MedicineDurvalumabOncologyAdjuvant chemotherapyChemotherapyInternal medicineAdjuvantCancerImmunotherapyNivolumabBreast cancerMedical Imaging Techniques and ApplicationsRadiomics and Machine Learning in Medical ImagingEsophageal Cancer Research and Treatment